Literature DB >> 12717262

Neural invasion in the staging of pancreatic cancer.

Parviz M Pour1, Richard H Bell, Surinder K Batra.   

Abstract

The natural history of pancreatic ductal adenocarcinoma makes it one of the most malignant human diseases. Unknown etiology, lack of early symptoms, explosive outcome, short survival, and resistance to therapy are hallmarks of this cancer. Although surgery has been shown to be an effective therapeutic approach, the inevitable tendency for recurrence, even after apparently curative operation, has remained a mystery. Ironically, the reasons for this recurrence, which usually leads to the death of the patient within 1 or 2 years after surgery, have not been a focus of research. Several studies highlighting this problem and the possible explanations have been performed by Japanese investigators.

Entities:  

Mesh:

Year:  2003        PMID: 12717262     DOI: 10.1097/00006676-200305000-00002

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  41 in total

Review 1.  Perineural invasion and associated pain in pancreatic cancer.

Authors:  Aditi A Bapat; Galen Hostetter; Daniel D Von Hoff; Haiyong Han
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  Preliminary study correlating CX3CL1/CX3CR1 expression with gastric carcinoma and gastric carcinoma perineural invasion.

Authors:  Cheng-Yu Lv; Tao Zhou; Wei Chen; Xin-Dao Yin; Jian-Hong Yao; Yi-Fan Zhang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.

Authors:  Hui-Lin Ye; Dou-Dou Li; Qing Lin; Yu Zhou; Quan-Bo Zhou; Bing Zeng; Zhi-Qiang Fu; Wen-Chao Gao; Yi-Min Liu; Rui-Wan Chen; Zhi-Hua Li; Ru-Fu Chen
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 4.  Prognostic value of perineural invasion in colorectal cancer: a meta-analysis.

Authors:  Yuchong Yang; Xuanzhang Huang; Jingxu Sun; Peng Gao; Yongxi Song; Xiaowan Chen; Junhua Zhao; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2015-02-07       Impact factor: 3.452

5.  RET Signaling in Prostate Cancer.

Authors:  Kechen Ban; Shu Feng; Longjiang Shao; Michael Ittmann
Journal:  Clin Cancer Res       Date:  2017-05-10       Impact factor: 12.531

Review 6.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 7.  Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.

Authors:  Han Liu; Qingyong Ma; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

8.  Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Dongjun Li; Douglas J Hartman; Howard C Crawford; Emily A Muha; Andrew D Rhim; Brian M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

9.  The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.

Authors:  Shizhi He; Shuangba He; Chun-Hao Chen; Sylvie Deborde; Richard L Bakst; Natalya Chernichenko; William F McNamara; Sei Young Lee; Fernando Barajas; Zhenkun Yu; Hikmat A Al-Ahmadie; Richard J Wong
Journal:  Mol Cancer Res       Date:  2014-10-13       Impact factor: 5.852

10.  Well-differentiated pancreatic ductal adenocarcinomas measuring ≤ 1 cm exhibit early features of tumor progression: a report of five lesions and a comparative study with advanced lesions.

Authors:  Sadanobu Izumi; Satoko Nakamura; Shohei Mano; Yuji Onoda
Journal:  Surg Today       Date:  2013-12-03       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.